Investigation of the Effect of Constraint Induced Movement Therapy Applied to the Lower Extremity on Lower Extremity Functions in Individuals With Unilateral Cerebral Palsy
Key facts
- Who runs it
- Abant Izzet Baysal University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 36 people, planned
- Started
- 15 Jan 2025
- Planned end
- 30 Jun 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- constraint induced movement therapy
- Control (Standard treatment)
- Record updated
- 31 December 2024
Who can take part
- Age
- 5 years to 15 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Having been diagnosed with Cerebral Palsy by a Child Neurologist
- Having been classified as Unilateral Cerebral Palsy according to SCPE
- Being between the ages of 5-15,
- Being at levels I-II according to the Gross Motor Function Classification System
- Being at levels I-II according to the Communication Function Classification System
- Being able to stand up from sitting independently, even with the help of the upper extremity
- Being able to walk at least 10 m with or without an assistive device
Who cannot take part
- Children who have had lower extremity orthopedic surgery within the last six months
- Children who have had lower extremity Botox injections within the last six months
- Those with rigid contractures involving lower extremity joints,
- Children with levels III-IV according to the Communication Functions Classification System
- Families and children who do not accept full participation in treatment
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 5 and 15 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Lower extremity constraint induced movement therapy has been applied to individuals with multiple sclerosis, stroke, subacute and chronic hemiparesis in recent years and positive results have been reported. However, there is no study in the literature regarding the application of this treatment method to the pediatric population. In order to address this gap in the literature, we planned to conduct this study to examine the possible effects of lower extremity constraint induced movement therapy on lower extremity functions, balance and gait parameters in individuals with cerebral palsy.
The 2 groups in the trial
- Constraint induced movement therapy groupExisting treatment, for comparison
Children in this group will receive constraint induced movement therapy in addition to conventional physical therapy twice a week.
Treatment: constraint induced movement therapy
- Control groupOther group
Children in this group will continue to receive their treatment twice a week at the special education and rehabilitation center where they are currently registered and attending.
Treatment: Control (Standard treatment)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Investigation of the Effect of Constraint Induced Movement Therapy Applied to the Lower Extremity on Balance, Gait and Lower Extremity Functions in Individuals With Unilateral Cerebral Palsy
- Fit questions
- Built from NCT06753812, who can take part
- Record updated
- 31 December 2024